BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1354919)

  • 1. What are the differences between abecarnil and conventional benzodiazepine anxiolytics?
    Stephens DN; Turski L; Hillman M; Turner JD; Schneider HH; Yamaguchi M
    Adv Biochem Psychopharmacol; 1992; 47():395-405. PubMed ID: 1354919
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators.
    Dazzi L; Motzo C; Imperato A; Serra M; Gessa GL; Biggio G
    J Pharmacol Exp Ther; 1995 Apr; 273(1):241-7. PubMed ID: 7714771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discriminative stimulus effects of abecarnil.
    Ator NA; Griffiths RR
    NIDA Res Monogr; 1990; 105():325. PubMed ID: 1678865
    [No Abstract]   [Full Text] [Related]  

  • 4. Anxiolytic and anxiogenic beta-carbolines: tools for the study of anxiety mechanisms.
    Stephens DN; Kehr W; Duka T
    Adv Biochem Psychopharmacol; 1986; 41():91-106. PubMed ID: 2874697
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral effects of chronic abecarnil administration in baboons.
    Sannerud CA; Griffiths RR
    NIDA Res Monogr; 1990; 105():328. PubMed ID: 1678866
    [No Abstract]   [Full Text] [Related]  

  • 6. Anxioselective anxiolytics: can less be more?
    Basile AS; Lippa AS; Skolnick P
    Eur J Pharmacol; 2004 Oct; 500(1-3):441-51. PubMed ID: 15464051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
    Löscher W; Hönack D; Scherkl R; Hashem A; Frey HH
    J Pharmacol Exp Ther; 1990 Nov; 255(2):541-8. PubMed ID: 1978730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.
    Mumford GK; Rush CR; Griffiths RR
    J Pharmacol Exp Ther; 1995 Feb; 272(2):570-80. PubMed ID: 7853170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abecarnil and palatability: taste reactivity in normal ingestion in male rats.
    Cooper SJ; Ridley ET
    Pharmacol Biochem Behav; 2005 Jul; 81(3):517-23. PubMed ID: 15935458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A pharmacological analysis of the anxiolytic action of derivations of benzodiazepine, GABA and beta-carboline in various tests of tension reaction].
    Talalaenko AN
    Farmakol Toksikol; 1989; 52(6):26-9. PubMed ID: 2576232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
    Steppuhn KG; Schneider HH; Turski L; Stephens DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1395-400. PubMed ID: 8095551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural and molecular mechanisms in anxiety.
    Wolkowitz OM; Paul SM
    Psychiatr Clin North Am; 1985 Mar; 8(1):145-58. PubMed ID: 2859577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
    Ozawa M; Sugimachi K; Nakada-Kometani Y; Akai T; Yamaguchi M
    J Pharmacol Exp Ther; 1994 May; 269(2):457-62. PubMed ID: 7910208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.
    Turski L; Stephens DN; Jensen LH; Petersen EN; Meldrum BS; Patel S; Hansen JB; Löscher W; Schneider HH; Schmiechen R
    J Pharmacol Exp Ther; 1990 Apr; 253(1):344-52. PubMed ID: 1970362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anxiolytic action of beta-carbolines in rats].
    Burov IuV; Orekhov SN; Vedernikova NN
    Biull Eksp Biol Med; 1985 Apr; 99(4):453-5. PubMed ID: 2859060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of epiphyseal melatonin and benzodiazepine anxiolytics].
    Arushanian ÉB
    Eksp Klin Farmakol; 2012; 75(3):35-40. PubMed ID: 22679752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abecarnil: a novel anxiolytic with mixed full agonist/partial agonist properties in animal models of anxiety and sedation.
    Stephens DN; Turski L; Jones GH; Steppuhn KG; Schneider HH
    Psychopharmacol Ser; 1993; 11():79-95. PubMed ID: 7908435
    [No Abstract]   [Full Text] [Related]  

  • 18. The validation of animal tests of anxiety--pharmacological implications.
    File SE
    Pol J Pharmacol Pharm; 1984; 36(5):505-12. PubMed ID: 6152493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral pharmacology of abecarnil in baboons: reduced dependence and abuse potential.
    Sannerud CA; Ator NA; Griffiths RR
    Psychopharmacol Ser; 1993; 11():113-20. PubMed ID: 7908430
    [No Abstract]   [Full Text] [Related]  

  • 20. Abecarnil is a full agonist at some, and a partial agonist at other recombinant GABAA receptor subtypes.
    Pribilla I; Neuhaus R; Huba R; Hillmann M; Turner JD; Stephens DN; Schneider HH
    Psychopharmacol Ser; 1993; 11():50-61. PubMed ID: 7908433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.